Losartan for Diffuse Myocardial Fibrosis in Sickle Cell Disease

Clinical trial NCT05012631 · COMPLETED

Trial details

NCT number: NCT05012631
Sponsor: Children's Hospital Medical Center, Cincinnati
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Sickle Cell Disease Diffuse Myocardial Fibrosis

Start date: 2021-09-01
Primary completion: 2025-10-03
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.